Trial site
Jena
- 12running trials
- 9closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia5 trials
- Multiple sclerosis3 trials
- Acute myeloid leukaemia2 trials
- Coronary artery disease2 trials
- Myelodysplastic syndromes2 trials
- Myeloproliferative neoplasms2 trials
- Prostate cancer2 trials
- Stroke2 trials
- Childhood cancers1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Diabetic eye disease1 trial
- Familial hypercholesterolaemia1 trial
- and 8 more
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 12 trials
- Phase 1/22 trials
- Phase 41 trial
- Status
- Active, not recruiting8 trials
- Completed7 trials
- Recruiting4 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals21 trials
Running trials
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
A Study of IDH305 in Patients With Advanced Malignancies That Harbor IDH1R132 Mutations
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
- Prostate cancer2 recruiting
Closed trials
Completed
Completed
Completed
Terminated
Completed
Terminated
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 17 Nov 2026